Personalisation of radiotherapy for breast cancer

Ian Kunkler, Carol Ward, Corey Speers, L Pierce, Felix Feng, James Meehan, Simon Langdon

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Abstract / Description of output

The role of radiotherapy is well established in the multidisciplinary management of breast cancer. However, its use could be customised further with the intent of enhancing tumour cell radiosensitisation and reducing normal cell toxicity. The importance of tumour heterogeneity and the microenvironment in the response to radiotherapy is under intense scrutiny and the value of molecular profiling is being increasingly recognised. Genome Wide Association Studies are likely to
play an important role in elucidating the molecular pathogenesis of radiotoxicity in the emerging area of radiogenomics. Biomarkers of tumour radiosensitivity should help indicate potentially responsive and unresponsive cancers. Further understanding of the tumour microenvironment and better preclinical models will help identify targets to enhance radiosensitivity or reverse radioresistance.
Original languageEnglish
Title of host publicationPersonalized Treatment of Breast Cancer
EditorsMasakazu Toi, Eric Winer, John Benson, Suzanne Klimberg
ISBN (Electronic)9784431555520
ISBN (Print)9784431555513
Publication statusPublished - Feb 2016


Dive into the research topics of 'Personalisation of radiotherapy for breast cancer'. Together they form a unique fingerprint.

Cite this